Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review
- PMID: 27370914
- PMCID: PMC5019973
- DOI: 10.1007/s40121-016-0117-y
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review
Abstract
Clostridium difficile infection (CDI) was once considered a primarily nosocomial concern. Emerging evidence from the last 20 years has highlighted a drastic shift in the known epidemiology of CDI, with disease outside of hospitals apparently occurring more frequently and causing severe disease in populations that were thought to be at low risk. This narrative review summarises potential pathways for infection outside of the hospital environment and highlights likely routes of transmission. Further, evidence is presented on potential risk factors for development of disease. Understanding the epidemiology of CDI outside of hospitals is essential to the ability to prevent and control disease in vulnerable populations.
Keywords: Animal reservoir/source; Clostridium difficile infection (CDI); Community-associated CDI; Epidemiology; Risk factors.
Figures
Similar articles
-
Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.J Clin Microbiol. 2016 Dec 28;55(1):216-225. doi: 10.1128/JCM.01779-16. Print 2017 Jan. J Clin Microbiol. 2016. PMID: 27807147 Free PMC article.
-
Epidemiology of Clostridium difficile infection.J Pharm Pract. 2013 Oct;26(5):464-75. doi: 10.1177/0897190013499521. J Pharm Pract. 2013. PMID: 24064435 Free PMC article. Review.
-
The evaluation of Clostridium difficile infection (CDI) in a community hospital.J Infect Public Health. 2015 Mar-Apr;8(2):155-60. doi: 10.1016/j.jiph.2014.08.002. Epub 2014 Oct 6. J Infect Public Health. 2015. PMID: 25301221
-
Clostridium difficile infection in the community: are proton pump inhibitors to blame?World J Gastroenterol. 2013 Oct 28;19(40):6710-3. doi: 10.3748/wjg.v19.i40.6710. World J Gastroenterol. 2013. PMID: 24187445 Free PMC article.
-
Clostridium difficile and One Health.Clin Microbiol Infect. 2020 Jul;26(7):857-863. doi: 10.1016/j.cmi.2019.10.023. Epub 2019 Nov 1. Clin Microbiol Infect. 2020. PMID: 31682985 Review.
Cited by
-
Faecal carriage of Clostridioides difficile is low among veterinary healthcare workers in the Netherlands.Epidemiol Infect. 2022 Feb 28;150:e63. doi: 10.1017/S0950268822000383. Epidemiol Infect. 2022. PMID: 35296372 Free PMC article.
-
High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.J Clin Microbiol. 2018 May 25;56(6):e00170-18. doi: 10.1128/JCM.00170-18. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29563206 Free PMC article.
-
Opportunities for Nanomedicine in Clostridioides difficile Infection.Antibiotics (Basel). 2021 Aug 5;10(8):948. doi: 10.3390/antibiotics10080948. Antibiotics (Basel). 2021. PMID: 34438998 Free PMC article. Review.
-
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota.Pharmaceuticals (Basel). 2016 Sep 29;9(4):62. doi: 10.3390/ph9040062. Pharmaceuticals (Basel). 2016. PMID: 27690060 Free PMC article. Review.
-
Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile.Saudi J Gastroenterol. 2019 Nov-Dec;25(6):384-389. doi: 10.4103/sjg.SJG_44_19. Saudi J Gastroenterol. 2019. PMID: 31793457 Free PMC article.
References
-
- Wilcox MH. Clostridium difficile infection. Hospital Doctor. 2005;1–8. ISSN 02623145.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources